Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00982189 · ClinicalTrials.gov registry record · NA
Cardiovascular Prevention for Persons With HIV
A NA study, sponsored by Hennepin Healthcare Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT00982189 is a NA study that has completed, run by Hennepin Healthcare Research Institute. The registered enrollment target is 37 participants.
The verdict
NCT00982189, a NA study, has completed, sponsored by Hennepin Healthcare Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
This study is funded by the American Heart Association. The goal of this research is to prevent early cardiovascular damage before symptoms develop for persons with HIV infection. Evidence suggests that taking low doses of blood pressure and cholesterol medication reduces risk for heart disease in persons who are at increased risk (such as the case with HIV infection). Participants who are taking HIV treatment with an 'undetectable' viral load, and who do NOT need treatment for high blood pressure or cholesterol may be eligible to enroll. Participants will take a low dose cholesterol medication (or placebo) and a low dose of a blood pressure medication (or a placebo), and will be seen at 3 study visits over 4 months.
Interventions
- DRUG Pravastatin
- DRUG Lisinopril
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2009-09 |
| Est. Completion | 2011-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00982189
The ClinicalTrials.gov registry entry for NCT00982189 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hennepin Healthcare Research Institute, which has 63 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pravastatin is the first listed.
NCT00982189 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00982189 about?
NCT00982189 is a clinical study titled "Cardiovascular Prevention for Persons With HIV". This study is funded by the American Heart Association. The goal of this research is to prevent early cardiovascular damage before symptoms develop for persons with HIV infection. Evidence suggests that taking low doses of blood pressure and cholesterol medication reduces risk for heart disease in p...
What is the current status of trial NCT00982189?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2009-09. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00982189?
The interventions under investigation include: Pravastatin (DRUG), Lisinopril (DRUG).
Who is sponsoring clinical trial NCT00982189?
This trial is sponsored by Hennepin Healthcare Research Institute, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.